And hsa-miR-182-3p/GPR15, hsa-miR-183-5p/PNOC, hsa-miR-625-5p/CCL21, hsa-miR-450-3p/VIP, hsa-miR-25-5p/SST, hsa-miR-454-5p/P2RY14, hsa-miR-490-3p/TPX2, hsa-miR-193a-5p/TRIP13, hsa-miR-6730-5p/CENPN, has-miR-490-5p/BRCA1 were verified to be negatively expressed in CRC, partly supporting the effectiveness of the networks. The gene discussed is VIP; the disease is colorectal carcinoma.